1 / 29

Adjuvant Chemotherapy for NSCLC- Where have we been and where are we going?

Adjuvant Chemotherapy for NSCLC- Where have we been and where are we going?. Fatima Zehra Raza Hematology/ Oncology Fellow pgy4- BCC. Typical New patient in Dr. Kloecker’s Friday Lung clinic- BCC 2nd floor.

chantale-scott
Download Presentation

Adjuvant Chemotherapy for NSCLC- Where have we been and where are we going?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Adjuvant Chemotherapy for NSCLC- Where have we been and where are we going? • Fatima Zehra Raza • Hematology/ Oncology Fellow pgy4- BCC

  2. Typical New patient in Dr. Kloecker’s Friday Lung clinic- BCC 2nd floor • 45 year old white woman with no previous comorbid conditions except a long history of smoking 2 ppd x 25 yrs, presents after being referred by pcp for a”spot” on her CXR. • FNAC of mass reveals adenocarcinoma, lung primary. • is status post complete surgical resection. Path reveals: poorly differentiated grade 3 adenocarcinoma, T2N0M0, stage 1B • What can you offer her?

  3. TNM STAGING CONTD....

  4. Typical New patient in Dr. Kloecker’s Friday Lung clinic- BCC 2nd floor • 45 year old white woman with no previous comorbid conditions except a long history of smoking 2 ppd x 25 yrs, presents after being referred by pcp for a”spot” on her CXR. • FNAC of mass reveals adenocarcinoma, lung primary. • is status post complete surgical resection. Path reveals: poorly differentiated grade 3 adenocarcinoma, T2N0M0, stage 1B • What can you offer her?

  5. Special Thanks to Dr. Kloecker!?s

More Related